CMPK2–mtDNA Axis Drives Doxorubicin Heart Damage, Study Finds
A mouse study identifies the mitochondrial enzyme CMPK2 as a key mediator of doxorubicin heart injury and reports that flavin adenine dinucleotide blocked the pathway without reducing antitumor efficacy. CMPK2–mtDNA Axis Drives Doxorubicin Heart Damage, Study Finds Subject of Research: The…